SIMRAN SEHBI: Open Payments
NPI 1215958582 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,498 in 81 payments from 12 companies in 2025. Trend: 2023 $3,965 · 2024 $4,132 · 2025 $2,498
Food & beverage: $2,494Education: $4
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $451 |
| Teva Pharmaceuticals USA, Inc. | 10 | $383 |
| E.R. Squibb & Sons, L.L.C. | 10 | $354 |
| Alkermes, Inc. | 11 | $262 |
| Otsuka America Pharmaceutical, Inc. | 14 | $261 |
| Neurocrine BioSciences, Inc. | 7 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $207 |
| Axsome Therapeutics, Inc. | 6 | $163 |
| Lundbeck LLC | 4 | $92 |
| ABBVIE INC. | 3 | $58 |
Products named: COBENFY, REXULTI, ARISTADA, SPRAVATO, INGREZZA, CAPLYTA, INVEGA SUSTENNA, UZEDY.
Industry payments across OH — which companies pay providers there.
